 Substance Withdrawal Syndrome
"Substance Withdrawal Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Descriptor ID |
D013375
|
| MeSH Number(s) |
C25.775.835 F03.900.825
|
| Concept/Terms |
Substance Withdrawal Syndrome- Substance Withdrawal Syndrome
- Substance Withdrawal Syndromes
- Syndrome, Substance Withdrawal
- Syndromes, Substance Withdrawal
- Withdrawal Syndrome, Substance
- Withdrawal Syndromes, Substance
Withdrawal Symptoms- Withdrawal Symptoms
- Symptom, Withdrawal
- Symptoms, Withdrawal
- Withdrawal Symptom
Drug Withdrawal Symptoms- Drug Withdrawal Symptoms
- Drug Withdrawal Symptom
- Symptom, Drug Withdrawal
- Symptoms, Drug Withdrawal
- Withdrawal Symptom, Drug
- Withdrawal Symptoms, Drug
|
Below are MeSH descriptors whose meaning is more general than "Substance Withdrawal Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Substance Withdrawal Syndrome".
This graph shows the total number of publications written about "Substance Withdrawal Syndrome" by people in this website by year, and whether "Substance Withdrawal Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 3 | 0 | 3 | | 1992 | 4 | 0 | 4 | | 1994 | 2 | 0 | 2 | | 1996 | 0 | 2 | 2 | | 1998 | 1 | 0 | 1 | | 1999 | 0 | 3 | 3 | | 2000 | 2 | 1 | 3 | | 2002 | 0 | 1 | 1 | | 2003 | 5 | 0 | 5 | | 2004 | 1 | 1 | 2 | | 2005 | 1 | 0 | 1 | | 2006 | 0 | 2 | 2 | | 2007 | 4 | 3 | 7 | | 2008 | 8 | 1 | 9 | | 2009 | 4 | 4 | 8 | | 2010 | 2 | 0 | 2 | | 2011 | 3 | 1 | 4 | | 2012 | 6 | 0 | 6 | | 2013 | 5 | 0 | 5 | | 2014 | 5 | 0 | 5 | | 2015 | 2 | 0 | 2 | | 2016 | 5 | 1 | 6 | | 2017 | 3 | 2 | 5 | | 2018 | 4 | 1 | 5 | | 2019 | 4 | 0 | 4 | | 2020 | 4 | 1 | 5 | | 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Substance Withdrawal Syndrome" by people in Profiles.
-
Ritvo AD, Calcaterra SL, Ritvo JI. Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series. J Addict Med. 2021 May-Jun 01; 15(3):252-254.
-
Cohen SP, Baber ZB, Buvanendran A, McLean BC, Chen Y, Hooten WM, Laker SR, Wasan AD, Kennedy DJ, Sandbrink F, King SA, Fowler IM, Stojanovic MP, Hayek SM, Phillips CR. Pain Management Best Practices from Multispecialty Organizations During the COVID-19 Pandemic and Public Health Crises. Pain Med. 2020 11 07; 21(7):1331-1346.
-
Schimmel J, Amioka E, Rockhill K, Haynes CM, Black JC, Dart RC, Iwanicki JL. Kratom use in the United States: Response to Grundmann et al. Addiction. 2021 01; 116(1):203-204.
-
Zhang XY, Li Q, Dong Y, Yan W, Song K, Lin YQ, Sun YG. Mu-Opioid Receptors Expressed in Glutamatergic Neurons are Essential for Morphine Withdrawal. Neurosci Bull. 2020 Oct; 36(10):1095-1106.
-
Terasaki D, Klie K. Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. J Addict Med. 2020 May/Jun; 14(3):264-266.
-
Gupta S, Wang C, Raetz EA, Schore R, Salzer WL, Larsen EC, Maloney KW, Mattano LA, Carroll WL, Winick NJ, Hunger SP, Loh ML, Devidas M. Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group. J Clin Oncol. 2020 06 10; 38(17):1897-1905.
-
Al-Mrayat YD, Okoli CTC, Studts CR, Rayens MK, Hahn EJ. The Psychometric Properties of the Minnesota Tobacco Withdrawal Scale Among Patients With Mental Illness. Biol Res Nurs. 2020 04; 22(2):247-255.
-
Ellingson JM, Bidwell LC, Hopfer CJ, Hutchison KE, Bryan AD. Correlates and Potential Confounds of Cannabis Withdrawal Among High-Risk Adolescents. J Stud Alcohol Drugs. 2019 09; 80(5):557-562.
-
Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029.
-
Regner MF, Tregellas J, Kluger B, Wylie K, Gowin JL, Tanabe J. The insula in nicotine use disorder: Functional neuroimaging and implications for neuromodulation. Neurosci Biobehav Rev. 2019 08; 103:414-424.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|